Common Characteristics in RA Patients Who Don’t Respond to Biologics
IV Meloxicam Stalls at FDA; Plus Health Canada Approves Risankizumab for Plaque Psoriasis
Health Canada Approves Certolizumab Pegol & NICE Issues Guidance for Certolizumab Pegol
Osteoporotic Fracture Rates Similar with Denosumab, Alendronate in Real World
IBD Patients Who Switch from Infliximab to Biosimilar See Mixed Results
Japan Approves Risankizumab for Psoriasis & Psoriatic Arthritis
Mirikizumab Promising for Plaque Psoriasis
Health Canada Approves Adalimumab for Chronic Non-Infectious Anterior Uveitis in Pediatric Patients
FDA Approves Guselkumab Injector
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 31
- Next Page »